# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007695
Filing Date
2024-05-10
Accepted
2024-05-10 07:20:49
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plx-20240331x10q.htm iXBRL | 10-Q | 891459
2 | EX-31.1 | plx-20240331xex31d1.htm | EX-31.1 | 12565
3 | EX-31.2 | plx-20240331xex31d2.htm | EX-31.2 | 12734
4 | EX-32.1 | plx-20240331xex32d1.htm | EX-32.1 | 6802
5 | EX-32.2 | plx-20240331xex32d2.htm | EX-32.2 | 6828
6 | GRAPHIC | plx-20240331x10q005.jpg | GRAPHIC | 113571
7 | GRAPHIC | plx-20240331x10q006.jpg | GRAPHIC | 100730
8 | GRAPHIC | plx-20240331x10q007.jpg | GRAPHIC | 53965
| Complete submission text file | 0001558370-24-007695.txt |  | 4574232

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | plx-20240331.xsd | EX-101.SCH | 30285
10 | EX-101.CAL | plx-20240331_cal.xml | EX-101.CAL | 37699
11 | EX-101.DEF | plx-20240331_def.xml | EX-101.DEF | 115177
12 | EX-101.LAB | plx-20240331_lab.xml | EX-101.LAB | 212130
13 | EX-101.PRE | plx-20240331_pre.xml | EX-101.PRE | 189843
59 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20240331x10q_htm.xml | XML | 510979

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 24932878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)